Plavix (Clopidogrel): Uses, Benefits, and Side Effects

Plavix (clopidogrel) belongs to the thienopyridine class of antiplatelet medications. It works by irreversibly blocking the P2Y12 adenosine diphosphate (ADP) receptor on platelets, preventing platelet activation and aggregation, thereby reducing the risk of blood clot formation.

Approved Uses

  • Reduction of atherothrombotic events in patients with recent myocardial infarction, recent stroke, or established peripheral artery disease.
  • Prevention of stent thrombosis in patients who have undergone percutaneous coronary intervention (PCI) with stent placement.
  • Reduction of cardiovascular events in patients with acute coronary syndrome (unstable angina/non-ST-elevation MI).

Mechanism of Action

Clopidogrel is a prodrug that requires hepatic metabolism via CYP450 enzymes (primarily CYP2C19) to generate its active metabolite. The active metabolite selectively inhibits ADP binding to its platelet P2Y12 receptor, impairing platelet aggregation for the lifespan of the platelet (7–10 days).

Common Side Effects

  • Bleeding (most common)
  • Bruising, nosebleeds, gastrointestinal hemorrhage
  • Diarrhea, abdominal pain, dyspepsia
  • Rash, itching

Important Considerations

  • Genetic variations in CYP2C19 (poor metabolizers) may reduce effectiveness; alternative agents (prasugrel, ticagrelor) may be considered.
  • Discontinuation before surgery should be guided by a physician (typically 5–7 days prior).
  • Concomitant use with other antithrombotics (aspirin, anticoagulants) increases bleeding risk.

Viral Infections - Related Articles